SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: ubernano, TomP1
Search This Board:
Last Post: 12/6/2016 8:45:04 AM - Followers: 409 - Board type: Free - Posts Today: 0

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
INO
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#13518  Sticky Note 2016 VALUE DRIVERS & MILESTONES (2nd-Half of 2016 Dr_Thorfin 08/01/16 01:50:30 PM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13729   Inovio MERS Vaccine Development to be Expanded with ubernano 12/06/16 08:45:04 AM
#13728   Gates gives Wistar $9 million for novel fight ubernano 12/03/16 12:47:11 PM
#13727   Inovio Pharmaceuticals' Next Zika Opportunity ubernano 12/01/16 07:30:58 PM
#13725   Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar ubernano 12/01/16 09:40:30 AM
#13724   Inovio’s Co-Founder and Chair of its Scientific Advisory ubernano 11/21/16 08:29:18 AM
#13723   What these anti INO comments lack in content ubernano 11/16/16 10:23:28 AM
#13722   MG, your link doesn't lead anywhere, much like ubernano 11/16/16 10:01:02 AM
#13721   have told you that i have made money fireopal 11/16/16 09:02:35 AM
#13720   Inovio Wins Deloitte’s “Fast 500” Growth Award Developer TomP1 11/16/16 08:31:40 AM
#13719   MiamiGent Member Level Monday, 08/05/13 08:23:15 AM MiamiGent 11/16/16 01:15:30 AM
#13718   MiamiGent Member Level Wednesday, 08/07/13 12:29:35 AM MiamiGent 11/16/16 01:13:45 AM
#13717   INO Might be helpful to new viewers to MiamiGent 11/16/16 12:55:16 AM
#13716   I hear you not refuting my assertion. That's boring. MiamiGent 11/16/16 12:40:55 AM
#13715   Singing the same song every day is rather borring... TomP1 11/16/16 12:37:44 AM
#13714   INO Listen to what the Dr Tara says MiamiGent 11/16/16 12:34:42 AM
#13713   have to admit that i was surprised this fireopal 11/15/16 10:44:21 PM
#13712   I did! ubernano 11/15/16 12:01:09 PM
#13711   Read the post to which i was replying... TomP1 11/15/16 11:58:42 AM
#13710   And what is even more important the share ubernano 11/15/16 09:41:45 AM
#13709   "proven rubbish"? ubernano 11/15/16 09:33:43 AM
#13708   They're trying. ubernano 11/15/16 09:26:56 AM
#13707   IMHHO, anything under $10 will be looked at ubernano 11/15/16 09:24:31 AM
#13706   Better inform DARPA, MedImmune,... that they are in TomP1 11/15/16 02:55:49 AM
#13705   It's a disreputable stock >> might want to fireopal 11/15/16 02:49:42 AM
#13704   Please post links for what you want me fireopal 11/15/16 01:36:43 AM
#13703  Restored See post 13630 MiamiGent 11/15/16 01:09:59 AM
#13702   Once again, sorry you missed this dip but fireopal 11/15/16 12:56:40 AM
#13701   See post 13691 MiamiGent 11/14/16 11:49:47 PM
#13700   sheesh Miami - Kim WAS NOT here 33 fireopal 11/14/16 11:09:57 PM
#13699   33 years and waiting. MiamiGent 11/14/16 11:04:38 PM
#13698   Fwtiw - i went back to his original fireopal 11/14/16 11:02:50 PM
#13697   INO Do you still maintain INO is curing MiamiGent 11/14/16 10:37:37 PM
#13696   INO Do you still maintain INO is better MiamiGent 11/14/16 10:30:05 PM
#13695   You truly were one of the very first fireopal 11/14/16 07:38:04 PM
#13694   i caught it at 10 cents! ubernano 11/14/16 06:11:32 PM
#13693  Restored Investment advice from anyone in south Florida about ubernano 11/14/16 06:09:38 PM
#13692   lol no different than any other company imo fireopal 11/14/16 04:32:32 PM
#13691   INO Oh no- same jerk, INO director MiamiGent 11/14/16 04:27:04 PM
#13690   same company in name only imo... fireopal 11/14/16 04:20:34 PM
#13689   But it is the same company! MiamiGent 11/14/16 04:18:45 PM
#13688   Maybe you missed my previous post so again, fireopal 11/14/16 04:16:28 PM
#13687   INO 33 years is too long for anyone MiamiGent 11/14/16 04:01:02 PM
#13686   INO obviously is here to stay and i fireopal 11/14/16 03:54:40 PM
#13685   That's right INO has not changed names since MiamiGent 11/14/16 03:41:27 PM
#13684   sheesh - has not changed names since Kim fireopal 11/14/16 03:35:39 PM
#13683   Hell no, that's a sucker's tip. MiamiGent 11/14/16 03:22:53 PM
#13682   Here's a tip: ubernano 11/14/16 03:05:15 PM
#13681   The market knows something you don't ubernano 11/14/16 03:04:45 PM
#13680  Restored INO Warning: INO is a PUMP & DUMP. MiamiGent 11/14/16 01:51:58 PM
#13679   Never Buy A Stock With More Name Changes MiamiGent 11/14/16 01:17:46 PM
PostSubject